Exclusive: Israeli life sciences investor NGT3 plans second fund

 Exclusive: Israeli life sciences investor NGT3 plans second fund
Israeli early-stage investment firm NGT3 is preparing to roll out a second fund as it looks to step up its bets on life sciences and medical devices companies, a top executive told The Capital Quest. Zohar Gendler, managing partner and chief executive officer at the Nazareth, Israel-based fund, said that […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.

Aman Malik

error: Content is protected !!
The Capital Quest